Millbont Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.40 M
- Revenue Growth -2.26%
- Profit Growth 0.95%
- Ebitda 7.44%
- Net Worth 29.21%
- Total Assets 16.14%
About Millbont Pharmaceuticals
Millbont Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 August 2007 and has a history of 17 years and six months. Its registered office is in Udaipur, Rajasthan, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.40 M.
Arvind Gupta, Dinesh Gupta, Kalpana Gupta, and Two other members serve as directors at the Company.
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232RJ2007PTC024894
- Company No.
024894
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
What products or services does Millbont Pharmaceuticals Private Limited offer?
Millbont Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Acne Drug, Isotretinoin Capsules, Bath Soaps, Medicated Soap, Antipyretic Medication, Paracetamol Tablets, Antifungal Injection, Tablet & Syrup, Fluconazole Tablet, Vitamin Tablets & Capsules, Methylcobalamin Tablets.
Who are the key members and board of directors at Millbont Pharmaceuticals?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Arvind Gupta ![]() | Director | 24-Aug-2007 | Current |
Anant Gupta ![]() | Director | 03-Oct-2014 | Current |
Dinesh Gupta ![]() | Director | 24-Aug-2007 | Current |
Kalpana Gupta ![]() | Director | 24-Aug-2007 | Current |
Harsh Gupta ![]() | Director | 26-Sep-2020 | Current |
Financial Performance of Millbont Pharmaceuticals.
Millbont Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.26% decrease. The company also saw a slight improvement in profitability, with a 0.95% increase in profit. The company's net worth Soared by an impressive increase of 29.21%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Millbont Pharmaceuticals?
In 2020, Millbont Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹2.40 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.24 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
16 Apr 2015 | State Bank Of India | ₹1.40 M | Open |
29 Aug 2008 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Millbont Pharmaceuticals?
Unlock and access historical data on people associated with Millbont Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Millbont Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Millbont Pharmaceuticals's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.